[12] Patent
[11] Patent No.:GC0009419  
[45] Date of Publishing the Grant of the Patent: 31/Dec /2018                56/2018  
Number of the Decision to Grant the Patent:2018/141926
Date of the Decision to Grant the Patent:19/Dec/2018

[21] Application No.:GC 2014-27450

[22] Filing Date:29/6/2014

[30] Priority:

[33] State [32] Priority date [31] Priority No.
US
28/6/2013
61/840,618

[72] Inventors:1- MACLEAN, DerekŲŒ2- YIN, Qun

[73] Owner: AMGEN INC., ONE AMGEN CENTER DRIVE , THOUSAND OAKS, CA 91320-1799, USA

[74] Agent: Saba & Co. T.M.P

  

 

  

[51]IPC:
Int. Cl.: A61K 38/08, 9/08; A61P 3/14, 5/00 (2006.01)

[56] Cited Documents:

-WO 2011/014707 A2 (KAI PHARMACEUTICALS INC[US]; KARIM FELIX [US]; BARUCH AMOS [US];MACL) 3 February 2011
 
Examiner: PH. Mohammad S. AlMousa

[54] STABLE LIQUID FORMULATION
[57] Abstract: A liquid formulation comprising a peptide agonist of the calcium sensing receptor and method of preparing and using the formulation are provided.
No. of claims: 15     No. of figures: 13


 

Note: Any interested individual may, within 3 months of publication of the grant, file objection thereof with the Grievance Committee after payment of grievance fees.